Clinical Trial Update: A Study Evaluating B Cell Levels In Infants Potentially Exposed To Ocrelizumab During Pregnancy [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating B cell levels in infants potentially exposed to ocrelizumab during pregnancy, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clinically Isolated Syndrome
• Multiple Sclerosis

Drugs mentioned

• Ocrelizumab (ocrelizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Multiple Sclerosis, Clinically Isolated Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2025-05-22